Mayne Pharma | MYX - Equity Capital And Reserves


Mayne Pharma reported AUD454.19M in Equity Capital and Reserves for its fiscal semester ending in June of 2024.





Equity Capital And Reserves Change Date
Ansell USD 1.97B 10.2M Dec/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Cochlear AUD 1.94B 12.2M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Healius AUD 1.03B 13.9M Dec/2024
Integral Diagnostics AUD 301.71M 1.33M Jun/2024
Medical Developments International AUD 54.77M 335K Dec/2025
Nanosonics AUD 219.69M 9.78M Dec/2025
Polynovo AUD 83.14M 121K Dec/2025
Ramsay Health Care AUD 4.79B 916.1M Dec/2025
ResMed USD 6.49B 171.03M Mar/2026
Sigma Healthcare AUD 4.67B 3.8B Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Telix Pharmaceuticals AUD 408.17M 8.69M Jun/2026